Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: options trading made simple with the IBKR Options Wizard.
Stocks/NASDAQ/ICU

SeaStar Medical Holding Corporation (ICU : NASDAQ)

$1.04USD+0.26 (33.16%)Close of 2026-11-18

Common Stock

Follow ICU

ICU

SeaStar Medical Holding Corporation

Source:WealthAwesomeWealthAwesome
↓ $2.45 (-70.20%)
30 day period
$0.78$2.32$3.85Oct 8Oct 29Nov 18

Performance

1 Day

+33.16%

1 Week

-45.83%

1 Month

-66.56%

YTD

-66.01%

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Key Statistics

Market Cap

$5.58M

52W High

$5.38

52W Low

$0.98

P/E Ratio

-

50 Day MA

$3.01

200 Day MA

$3.31

Beta

-1.04

Dividend Yield

-

Performance history

ICU returns since 2026

SeaStar Medical Holding Corporation has traded since Jun 2026 in our data. Its deepest fall was −84.6% (Jul 2026 to Nov 2026).

1 year / yr

—

3 years / yr

—

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2026*−66.0%

* Partial year (first year of data, or year to date).

$10,000 invested in ICU

  • 2026 (start of our data)$3,399
All-time high in our data
$5 on Jul 8, 2026 · now −79.5%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.

Awesome Portfolio™

Looking past ICU? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/18/2026$0.83$1.07$0.76$1.04$1.04683,262
11/17/2026$0.89$0.89$0.78$0.78$0.78142,880
11/16/2026$0.80$0.86$0.79$0.85$0.85183,485
11/13/2026$1.08$1.08$0.81$0.84$0.84598,700
11/12/2026$1.21$1.31$0.98$1.05$1.05798,842
11/11/2026$1.89$2.00$1.85$1.92$1.92141,834
11/10/2026$1.96$1.97$1.90$1.90$1.9036,193
11/9/2026$1.92$2.00$1.84$1.96$1.96140,987
11/6/2026$1.93$1.99$1.88$1.88$1.8858,400
11/5/2026$2.04$2.06$1.89$1.92$1.9284,889

Analyst Price Targets

Based on 1 analyst covering ICU · as of Sep 17, 2026

📈

Wall Street analysts forecast ICU stock price to rise 861.5% over the next 12 months.

Consensus

Buy

4.00 / 5.00

Avg. Target

US$10.00

+861.5% Upside

Current Price

US$1.04

Last close

Analyst Breakdown (1 analysts)

Buy 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ICU's historical volatility

HistoricalForecast68%95%
US$0.06US$2.60US$5.15US$7.70US$10.24US$12.79TodayJul 15Sep 17Nov 18Dec 31Feb 13Mar 28

30-Day Vol

222.4%

Annualized

90-Day Vol

157.3%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

US$0.87

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$0.98US$0.45 – US$2.11
60 trading daysUS$0.92US$0.31 – US$2.73
90 trading daysUS$0.87US$0.23 – US$3.29

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Financials

Revenue (TTM)
$1.71M
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
-356.87%
EPS (Diluted)
-2.97
Book Value
1.01

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Tuesday Stock Pick

Tuesday morning

One Canadian stock and the case for it

  • The name with the biggest gap to analyst targets
  • The chart, insider buying and what is driving it
  • A plain-English bottom line, no hype

Free. One email a week. Unsubscribe any time.

Common Questions About ICU.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SKYASkyAI, Inc.$4.13+90.32%
CUECue Biopharma$4.76+68.20%
CLROClearOne Inc$6.90+46.19%
AZIAutozi Internet Technology (Global) Ltd. Class A Ordinary Shares$1.04+42.45%
NURNuran Wireless Inc. Common Shares$0.50+33.76%
ANPARich Sparkle Holdings Limited Ordinary Shares$1.40+33.33%
HIHOHighway Holdings Limited$1.61+30.89%
HPAIHelport AI Limited Ordinary Shares$0.26+27.23%

Free with a Wealth Awesome account

Keep analysing ICU, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.